PROGRAMMA
QUICK MENU
27th AISF PRE-MEETING COURSE
MARCH 18th, 2026 >
58th AISF ANNUAL MEETING
MARCH 19th, 2026 >
MARCH 20th, 2026 >
27th AISF PRE-MEETING COURSE
MARCH 18th, 2026
AUDITORIUM
10:40-11:00
INTRODUCTION
AISF Governing Board
11:00-12:20
SESSION I – ACUTE HEPATITIS AND ACUTE LIVER FAILURE
Chairs: R. D’Ambrosio, G. Marrone
11:00
Acute immune-mediated liver injury: new challenges for an old paradigm – A. Lleo
11:15
Managing severe alcohol-related hepatitis: are we all on the same page? – G. Perricone
11:30
Acute liver failure: from early assessment to advanced medical support – S. Martini
11:45
Liver transplantation for acute liver failure: is it time for new selection criteria? – C. Morelli
12:00
Discussion
12:20-12:50
STATE OF THE ART LECTURE
Improving outcomes in critically ill liver patients: the role of clinical care networks – V. Calvaruso
Introduction: G. Germani
EXHIBITION AREA
12:50-13:50
Lunch
AUDITORIUM
13:50-15:10
SESSION II – ACUTE COMPLICATIONS AND ACUTE ON CHRONIC LIVER FAILURE
Chairs: P. Caraceni, S. Gitto
13:50
Acute renal dysfunction: updated definition and treatment options – S. Piano
14:05
Acute splanchnic vein thrombosis: medical therapy vs. interventional radiology – F. Schepis
14:20
ACLF: epidemiology and evolving standards of care – G. Zaccherini
14:35
ACLF and liver transplantation: who benefits most? – V. Giannelli
14:50
Discussion
15:10-16:15
SESSION III – BLEEDING AND COAGULOPATHY
Chairs: F. Tovoli, F. Vizzutti
15:10
Integrating medical and endoscopic therapies in variceal bleeding – G. Tosetti
15:25
When endoscopy is not enough: the role of interventional radiology – M. Senzolo
15:40
Beyond INR: understanding the rebalanced haemostasis in liver disease – V. La Mura
15:55
Discussion
EXHIBITION AREA
16:15-16:45
Coffee Break
AUDITORIUM
16:45-18:05
SESSION IV – CRITICAL CARE AND MULTIDISCIPLINARY MANAGEMENT
Chairs: G. Svegliati Baroni, U. Vespasiani Gentilucci
16:45
Sepsis in cirrhosis: risk stratification and intervention strategies – M. Bartoletti
17:00
Treating alcohol withdrawal syndrome in the setting of liver disease – G. Addolorato
17:15
Pregnancy and liver disease: managing a complex intersection – P. Burra
17:30
ICU care of patients with cirrhosis: a fine line between utility and futility – P. Persona
17:45
Discussion
18:05-18:10
GENERAL ASSEMBLY 1 (No E.C.M.)
AISF Governing Board
PARALLEL SESSION (No E.C.M.)
AUDITORIUM
18:15-19:15
RARE BUT NOT STRAIGHTFORWARD: PBC AND PFIC AMONG CHALLENGES, INNOVATION, AND REAL WORLD EVIDENCE
Chairs: M. Brunetto e D. Alvaro
- Primary Biliary Cholangitis: from Pathophysiology to Symptom Management
M. Marzioni - Primary Biliary Cholangitis: Real World Evidence and Impact on Clinical Management
M. Viganò - Genetic Cholestasis: Diagnosis, Therapy, and Management in Clinical Practice
L. Cristoferi
ROOM GH
18:15-18:45
USTRIDE IN HCC: A JOURNEY BEYOND THE EDGE OF THE LINICAL TRIAL
Chair: M. Iavarone
Speakers: C. Celsa, C. Mazzarelli
18:45-19:45
GENETIC CHOLESTATIC DISEASES AND PRIMARY CHOLANGITIS: SYMPTOMS, DIAGNOSTIC CHALLENGES, AND NEW THERAPEUTIC OPTIONS
Chairs: V. Calvaruso, P. Invernizzi
- PFIC in adults: the diagnostic challenge and new therapeutic options
L. Fabris - Cholestatic pruritus: a symptom and common feature of genetic cholestatic diseases and primary cholangitis
M. Carbone - Primary sclerosing cholangitis viewed through its symptomatic manifestations and its impact on patients’ quality of life
A. Lleo
PININFARINA
18:15-18:45
REAL-WORLD EVIDENCE IN WILSON DISEASE: CLINICAL EXPERIENCE AND PRACTICAL CHALLENGES
Chair: Massimo Zuin
- SESSION 1
Real-life of Trientine tetrahydrochloride in adult patients with Wilson Disease: a 3 years experience in Italy
N. Cazzagon - SESSION 2
Challenges in the usage of traditional therapies
C. Cantisani
58th AISF ANNUAL MEETING
MARCH 19th, 2026
EARLY MORNING WORKSHOP (No E.C.M.)
ROOM GH
08:00-08:45
NEW PERSPECTIVES ON LIVER TRANSPLANTATION FOR ALCOHOL-RELATED LIVER DISEASE
Chairs: N. De Maria, A. Ferrarese
PININFARINA
08:00-08:45
MULTIDISCIPLINARY MANAGEMENT OF HCC
Chairs: C. Mazzarelli, A. Vitale
ROOM A
08:00-08:45
THE EVOLVING CHALLENGE OF INFECTIONS IN CIRRHOSIS
Chairs: N. Coppola, V. Zuccaro
ANNUAL MEETING
AUDITORIUM
08:50-09:00
WELCOME & INTRODUCTION
AISF Governing Board
09:00-10:00
GENERAL SESSION 1
Chairs: A. Aghemo, L. Miele
Transjugular Intrahepatic Portosystemic Shunt in Patients with Portosinusoidal Vascular Disorder: A Retrospective Multicentre International Study from the Vascular Liver Diseases Group (VALDIG)
Presenter: Laura Turco (Bologna)
Authors: L. Turco, F. Schepis, D. Saltini, F. Vizzuti, M. Viganò, S. Fagiuoli, C. Becchetti, A. Airoldi, S. Nardelli, S. Gioia, A. Zanetto, E. Pinto, K. Ferdinande, M.G. Indre, M.C. Morelli, G. Tosetti, F. Santopaolo, N. Pugliese, D. Sacerdoti, M. Senzolo
Bologna, Modena, Florence, Bergamo, Milan, Rome, Padua, Pieve Emanuele (MI), Rozzano (MI), Verona
Mechanistic and therapeutic insight into the ATG7 p.V471A variant role in MASLD progression
Presenter: Alessandra Cazzaniga (Milan)
Authors: A. Cazzaniga, S. Frigo, A. Cherubini,
G. Baselli, L. Cerami, V. Vaira, L. Valenti
Milan, Stockholm (Sweden)
Bulevirtide monotherapy prevents liver decompensation in patients with hdv-related cirrhosis: a case control study with propensity score weighted analysis
Presenter: Elisabetta Degasperi (Milan)
Authors: E. Degasperi, A. De Silvestri, D. Roulot, M.P. Anolli, L. Gheorghe, M. Chitul, C. Schramm, H. Schmidt, M. Jachs, T. Reiberger, J. Foucher, S. Metivier, M. Buti, A. Palom, G. D’Offizi, F. Di Maria, C. Zöllner, F. Tacke, C. Dietz-Fricke, H. Wedemeyer, M. Papatheodoridi, G. Papatheodoridis, I. Carey, K. Agarwal, F. Van Bömmell, M.R. Brunetto, M. Cardoso, E. Rosselli Del Turco, A. Ciancio, S. Lens, Á. Giráldez-Gallego, F. Zoulim, S. Aleman, N. Semmo, A. Mangia, M.N. Hilleret, U. Merle, T.A. Santantonio, N. Coppola, A. Pellicelli, B. Roche, X. Causse, L. D’Alteroche, J. Dumortier, N. Ganne, F. Heluwaert, I. Ollivier, M. Viganò, A. Federico, F. Pileri, M. Maracci, M. Tonnini, J.-P. Arpurt, K. Barange, E. Billaud, S. Pol, A. Gervais, A. Minello, I. Rosa, M. Puoi, J. Flaherty, P. Lampertico
Milan, Pavia, Bobigny (France),Bucarest (Romania). Essen (Germany), Vienna (Austria), Bordeaux (France), Toulouse (France), Barcelona (Spain), Rome, Berlin (Germany), Hannover (Germany), Athens (Greece), London (UK), Leipzig (Germany), Pisa, Amadora (Portugal), Bologna, Turin,Sevilla (Spain), Lyon (France), Stockholm (Sweden), Bern (Switzerland), San Giovanni Rotondo (FG), Grenoble (France), Heidelberg (Germany), Foggia, Naples, Villejuif (France), Orléans (France), Tours (France), Annecy (France), Caen (France), Bergamo, Modena, Ancona, Avignon (France), Paris (France), Dijon (France), Créteil (France), Foster City (USA)
Complete pathological response following liver transplatation for hepatocellular carcinoma (hepaclear). Absolute benefit or waste of resources?
Presenter: Giammauro Berardi (Rome)
Authors: G. Berardi, A. Cucchetti, C. Sposito, A. Vitale, M. Colasanti, L. Di Cesare, M. Serenari, S. Di Sandro, F. Falaschi, G. Vennarecci, F. Di Benedetto, U. Cillo, M. Cescon, V. Mazzaferro, G.M. Ettorre
Rome, Forlì, Milan, Padua, Bologna, Modena, Naples
Exploring PD-L1–Induced Immune Remodeling in Cholangiocarcinoma through a Human-Derived Organ-on-Chip System
Presenter: Sofia Buzzi (Rozzano, MI)
Authors: S. Buzzi, M.A. Polidoro, G. Montorsi, C. Soldani, B. Franceschini, A. Gazzillo, A. Cammarota, F. Milana, G. Torzilli, P. Occhetta, M. Rasponi, A. Lleo
Rozzano (MI), Milan
10:00-10:30
STATE OF THE ART LECTURE
Redefining the hepatologist’s role in the (dys)metabolic era: challanges and opportunites
Z. Younossi
Presenter: E. Bugianesi
EXHIBITION AREA
10:30-11:00
Coffee Break
AUDITORIUM
11:00-12:00
SYMPOSIUM I – STEATOTIC LIVER DISEASE AND ALCOHOL-RELATED LIVER DISEASE
Chairs: A. Gasbarrini, S. Petta
11:00
Targeting the liver and beyond: current and emerging therapies for MASLD – F. Marra
11:15
MetALD: a diagnostic dilemma or a new disease entity? – A. Federico
11:30
New horizons in ArLD management: integrating emerging therapies into clinical care – L. Abenavoli
11:45
Discussion
12:00-12:30
POLICY, PUBLIC HEALTH AND ADVOCACY NETWORK
National strategies for prevention of liver disease: from policy to practice
Modera: Daniel della Seta
Si prevede la partecipazione di:
On. L. Ciocchetti, M. Conforti, G. Germani, On. G. Girelli, L. Kondili, Sen. G.Q. Liris*, On. S. Loizzo, F.S. Mennini*, Sen. E. Murelli
12:30-12:45
AISF CAREER AWARD (No E.C.M.)
A.L. Zignego
Presenter: M. Brunetto
EXHIBITION AREA
12:45-13:45
LUNCH & POSTER VIEW
AUDITORIUM
13:45-14:45
SYMPOSIUM
COMMISSIONE PERMANENTE TRAPIANTO (CPT)
ONE PATIENT, MANY VOICES: CHALLENGES IN MULTIDISCIPLINARY TRANSPLANT CARE
Chairs: C. Becchetti, D. Pagano, G. Svegliati Baroni
Introduction – V. Giannelli
Diabetes and obesity around liver transplantation: innovative pharmacological and surgical strategies – C. Morelli
Tailoring immunosuppression: when etiology shapes therapy – G. Marrone
Rare indications for adult liver transplantation: a multidimensional approach to improve outcomes – P. Toniutto
Take Home Messages – P. Burra
SALA DELL’ARCHITETTURA + SALA DELL’EDITORIA
13:45-14:45
PORTAL HYPERTENSION LAB (No E.C.M.)
F. Schepis, M. Senzolo, L. Turco, F. Vizzutti
AUDITORIUM
14:45-15:30
AISF-CLEO JOINT SESSION
ADVANCES IN THE MULTIDIMENSIONAL MANAGEMENT OF CIRRHOSIS
Chairs: G. Germani, R. Sacco
14:45
Practical approaches to sarcopenia evaluation in cirrhotic patients – P. Gallo
14:55
Disease-modifying treatments in cirrhosis: an update – E. Degasperi
15:05
The role of digital health in cirrhosis management – M. Distefano
15:15
Discussion
ROOM GH
14:45-15:30
PARALLEL SESSION 1
Chairs: A. Armandi, N. Cazzagon
A prospective multicenter study to examine the impact of acquired and genetic predictors on Hepatocellular carcinoma risk in patients with advanced MASLD
Presenter: Stefania Mira (Milan)
Authors: S. Mira, S. Pelusi, L. Miano, F. Malvestiti, G. Periti, L. Ronzoni, M. Saracino, R. D’Ambrosio, L. Miele, A. Liguori, E. Bugianesi, C. Rosso, P. Dongiovanni, G. Soardo, S. Petta, G. Pennisi, U. Vespasiani Gentilucci, F. Tavaglione, A. Federico, F.P. Russo, P. Zanaga, M. Masarone, D. Prati, L. Valenti
Milan, Pavia, Rome, London (UK), Torino, Udine, Palermo, La Jolla (USA), Naples, Padua, Baronissi (SA)
Mapping the hepatic mtDNA genomic landscape in patients with MASLD: The Era of GPT-4 Artificial Intelligence
Presenter: Miriam Longo (Milan)
Authors: M. Longo, E. Paolini, M. Meroni, A.L. Fracanzani, P. Dongiovanni
Milan
Diagnostic yield and clinical correlates of inherited cholestatic gene variants in adult-onset cryptogenic cholestasis: an Italian multicentre experience
Presenter: Filippo Gabrielli (Modena)
Authors: F. Gabrielli, F. Caputo, A. Bono, F. Ravaioli, S. Ferrari, A. Vaisfeld, C. Paone, L. Turco, M.C. Morelli, I. Costa, A. Bruni, L. Colecchia, E. Dajti, F. Girolami, E. Bernasconi, A. Centofanti, A. Conti, P. Andreone, F. Azzaroli, F. Piscaglia, G. Vitale
Modena, Bologna
Heterogeneous cardiometabolic patterns influence hepatocellular carcinoma risk and trajectories in advanced fibrosis-affected MASLD patients
Presenter: Mario Romeo (Caserta)
Authors: M. Romeo, M. Dallio, F. Di Nardo, C. Napolitano, P. Vaia, C. Basile, A. Scafuri, G. Martinelli, M. Niosi, A. Federico
Caserta
PININFARINA
14:45-15:30
PARALLEL SESSION 2
Chairs: C. Balsano, A. Gerussi
Real-world experience of fibrates as second-line therapies in patients with primary biliary cholangitis: data from the Italian PBC Registry
Presenter: Laura Cristoferi (Monza)
Authors: L. Cristoferi, E. Nofit, A. Nardi, N. Cazzagon, E. Bonaiuto, P. Lampertico, E. Degasperi, V. Calvaruso, M. Neglia, G. Genova, V. Di Marco, U. Vespasiani Gentilucci, F. Terracciani, A. Lleo, F. Colapietro, E. Vanni, A. Risso, S. Fagiuoli, F. Azzaroli, E. Daijti, F. Losito, R. Cozzolongo, R. Viganò, F. D’Amico, F. Morisco, V. Cossiga, M. Russello, M. Cannavò, A. Castellaneta, A. De Feudis, M. Brunetto, B. Coco, M. Marzioni, L. Maroni, E.G. Giannini, S. Labanca, F. Cerini, F. Pavan, V. Pace Palitti, A. Andreone, F. Gabrielli, C. Rigamonti, G. Manfredi, G. Vitale, M.C. Morelli, G. Niro, R. Cotugno, L. Napoli, F. Foschi, A. Galli, A. Curto, E.N. Lynch, M. Persico, M. Masarone, D. D’Amato, A. Gerussi, G. Missale, A. Orlandini, G. Alagna, A. Granito, F. Piscaglia, G. Raimondo, C. Saitta, D. Alvaro, S. Nardelli, D. Montecalvo, F. Bellanti, S. Quiete, G. Vettori, L. Moser, A. Mega, M. Zoeschg, A. Federico, F. Di Nardo, F.R. Ponziani, F. Fianchi, I. Cavalli, A. Gobbi, C. Cusumano, C. Agnolon, N. Passigato, F. Capelli, L. Pitotti, L. Baiocchi, P. Carnì, L. Surace, E. Falbo, T. Zolfino, C. Scudu, C. Ricci, P. Poisa, L. Fabris, A. Lasagni, P. Lecis, A. Meneghetti, L. Abenavoli, G.G.M. Scarlata, A. Baragiotta, L. Chessa, F. Pes, S.L. Crocè, F. Masutti, M.C. Bragazzi, R. Venere, F. Bronte, A. Affronti, P. Invernizzi, M. Carbone, M. Viganò
Monza, Rome, Padova, Milano, Palermo, Rozzano, Torino, Bergamo, Bologna, Castellana Grotte, Napoli, Catania, Bari, Pisa, Ancona, Genova, Pescara, Modena, Novara, San Giovanni Rotondo (FG), Faenza, Firenze, Salerno, Parma, Sassari, Messina, Foggia, Trento, Bolzano, Cremona, Verona, Legnano, Lamezia Terme, Cagliari, Brescia, Bassano del Grappa, Catanzaro, Pordenone, Trieste, Latina
A multimodal artificial intelligence approach for predicting therapeutic decisions in hepatocellular carcinoma: integrating clinical and imaging data
Presenter: Ciro Celsa (Palermo)
Authors: C. Celsa, S. Contino, M. Giuffrè, A. Grova, G. Di Maria, R. Cannella, L. Cruciata, R. Ciccia, M. Salvato, S. Restuccia, G. Giusino, A. Quartararo, G. Cusimano, A. Sparacino, V. Gaudioso, C. La Mantia, F. Mercurio, S. Kresevic, M. Ajcevic, G. Cabibbo, G. Cirrincione, R. Pirrone, C. Cammà
Palermo, London (UK), Yale, New Haven, Connecticut, USA, Trieste, Amiens (France)
Large extracellular vesicles fingerprint of PSVD reveals an endothelial-platelet activation and immune dysregulation
Presenter: Elisa Pinto (Padua)
Authors: E. Pinto, A. Zanetto, K. Ferdinande, E. Campello, C. Bulato, S. Toffanin, S. Gavasso, P. Simioni, M. Senzolo
Padua
SARCIRAM: A Pilot Study On The Impact Of Hydroxiram D Supplementation On Sarcopenia In Patients With Liver Cirrhosis
Presenter: Paolo Gallo (Rome)
Authors: P. Gallo, L. Santoro, D. Marcelli, V. Flagiello, F. Terracciani, A. Falcomatà, A. De Vincentis, A. Picardi, U. Vespasiani-Gentilucci
Rome
AUDITORIUM
15:30-15:45
GENERAL ASSEMBLY 2 (No E.C.M.)
AISF Governing Board
15:45-16:45
SYMPOSIUM II – VIRAL HEPATITIS AND CASCADE OF CARE IN 2026: WHERE DO WE STAND?
Chairs: B. Coco, P. Lampertico
15:45
Advances and unmet needs in HCV, HBV and HDV screening – F.P. Russo
16:00
Linkage to care: addressing obstacles to bridge the gap – M. Masarone
16:15
Personalized treatment of viral hepatitis: overcoming past barriers – M.R. Brunetto
16:30
Discussion
16:45-17:45
GENERAL SESSION 2
Chairs: C. Cammà, L. Valenti
Development of new criteria for early response to terlipressin and albumin in patient with Hepatorenal Syndrome – Acute Kidney Injury
Presenter: Valeria Calvino (Padua)
Authors: V. Calvino, S. Incicco, R. Gagliardi, N. Zeni, G. Antonacci, C.G. Gambino, M. Tonon, P. Angeli, S.S. Piano
Padua
Microbiota-driven break of B cell tolerance promotes spontaneous anti-HBsAg seroconversion in HBV transgenic mice
Presenter: Valeria Fumagalli (Milan)
Authors: M. Grillo, C. Perucchini, P. Di Lucia, C. Beccaria, C. Abbot, M. Ravà, Giustini, E. Bono, S. Becattini, L. Guidotti, V. Fumagalli, M. Iannacone,
Milan, Genoa
Evaluating Non-invasive Eligibility Criteria for Resmetirom in Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD): Real-world Data from an Italian Multicentric Cohort
Presenter: Nicola Pugliese (Rozzano, MI)
Authors: N. Pugliese, D. Polverini, A. Bertazzoni, F. Cerini, R. Lombardi, G. Pennisi, S. De Nicola, C. Masetti, A.L. Fracanzani, M. Viganò, S. Petta, A. Aghemo
Rozzano (MI), Milan, Palermo, Bergamo
Uncovering the role of cell-intrinsic PD-1 in the response to PD-1 blockade in hepatocellular carcinoma
Presenter: Andrea Arleo (Bologna)
Authors: A. Arleo, A. Montagner, C.S. Cioroianu, F. Vasuri, F. Piscaglia, L. Gramantieri, C. Giovannini
Bologna, Ravenna
Liver Transplantation for Wilson’s Disease: a study from the ELTR database
Presenter: Alberto Ferrarese (Padua)
Authors: A. Ferrarese, F. Pelizzaro, R. Adam, S. Darwish Murad, V. Karam, S. Yilmaz, M. Heneghan, M. Grat, D. Mirza, M. Schmelzle, D. Cherqui, M. Zeytunlu, J. Pratschke, A. Paul, G. Berlakovich, F.P. Russo, A. Zanetto, N. Cazzagon, G. Germani, P. Burra
Padua, Villejuif (France), Rotterdam (Netherlands), Paris (France), Malatya (Turkey), London (UK), Warsaw (Poland), Birmingham (UK), Hannover (Germany), Izmir (Turkey), Berlin (Germany), Essen (Germany), Wien (Austria)
PARALLEL SESSION (No E.C.M.)
AUDITORIUM
17:50-18:50
WRITING THE FUTURE OF PBC CARE
Chair: D. Alvaro
- Welcome and Introduction
Chair: D. Alvaro - Driving Innovation in Liver Disease
M. Aboud - The Power of selectivity: Translating Seladelapar’s Mechanism into Clinical Value
M. Fornai - From Selectivity to Clinical impact: Seladelpar Efficacy and Safety from Trials to Real World Evidence
L. Cristoferi, F. Terracciani - ROUND TABLE
The Evolution of PBC Care: from Deep Response to Patients’ Well-being
Conduce: P.L. Toniutto
Discussants: V. Calvaruso, A. Lleo De Nada, D. Salvioni, M. Viganò - Wrap up e Chiusura
Chair: D. Alvaro
18:50-19:20
MEET THE EXPERT
TALKING ABOUT LIVER HEALTH: IMPROVING COMMUNICATION FOR BETTER CARE
Chair and Moderator: P. Lampertico
- Welcome and Introduction
P. Lampertico - Empowering Conversations: Expanding Options Together in PBC
N. Cazzagon - Shaping the Future of HDV Care: from Starting Therapy to Staying on Treatment: The Power of Shared Decision-Making
C. Taibi - Wrap up and Conclusions
P. Lampertico
ROOM GH
17:50-18:50
SHAPING THE FUTURE FOR PATIENTS WITH MASH: EMERGING TARGETS AND TRANSFORMATIVE THERAPIES
Chairs: A. Aghemo, E. Bugianesi
- Welcome and introduction
A. Aghemo, E. Bugianesi - Redesigning the diagnostic pathway from screening to staging in MASH
L. Miele - Decoding MASH progression through inflammatory and fibrotic drivers
F. Marra - The imperative to act: how the emerging MASH therapies are poised to transform patient care
S. Petta - Panel discussion (concerning MASH) and Q&A
A. Aghemo, E. Bugianesi, F. Marra, L. Miele, S. Petta
PININFARINA
17:50-18:50
ACCELERATE THE TEST&TREAT APPROACH IN HCV MANAGEMENT AT HOSPITAL LEVEL
Chair: A. Gasbarrini
- Test now. Treat now. The value of short therapy in HCV complicated patients
M. Persico
MARCH 20th, 2026
AUDITORIUM
09:00-10:00
GENERAL SESSION 3
Chairs: S. Montagnese, F. Piscaglia
Longitudinal Assessment of Body Composition and Its Prognostic Impact After TIPS in Cirrhosis: A Prospective Multicentre study (NutriTIPS group)
Presenter: Simone Di Cola (Rome)
Authors: S. Di Cola, J. Gazda, D. Saltini, G. Polidori, C. Sorgenti, A. Mastro, L. Maruzzelli, G. Cusi, A. Barrancotto, L. Lapenna, F. Gentili, R. Miraglia, S. Nardelli, S. Gioia, F. Vizzutti, F. Schepis, M. Merli
Rome, Italy, Kosice (Slovakia), Modena, Florence, Palermo
Prognostic impact of pulmonary hypertension phenotypes and severity in asymptomatic patients with compensated cirrhosis: insights from a large cohort
Presenter: Dario Saltini (Modena)
Authors: D. Saltini, A. Piscopo, T. Guasconi, M. Bianchini, A. Salomè Velasco Mayorga, G. Catania, N. Giglio, F. Scianò, F. Milosa, M.R. Critelli, A. Colecchia, F. Schepis
Modena
Biochemical Response Criteria Predict Transplant-Free Survival Across Disease Stages in Primary Biliary Cholangitis: Findings From the FiOCA Study
Presenter: Vincenzo Ronca (Pieve Emanuele, MI)
Authors: V. Ronca, A. De Vincentis, A. Tanaka, C. Corpechot P. Trivedi, F. Terracciani, L. Cristoferi, G. Cancado, M. Scaravaglio, N. Cazzagon, N. Abbas, K. Olsen, S. Rodriguez-Tajes, A. Martins, F. Colapietro, M.C. Londoño, N. Gatselis, V. Lygoura, E. Lytvyak, A. Montano-Loza, A. Gerussi, E. Culver, G. Dalekos, D. D’Amato, A. van der Meer, F. Nevens, E. Zigmond, V. Calvaruso, L. Sierra, R. Barba, A. Bonder, A. Villamil, X. Verhelst, C. Levy, H. Ytting, R. Viganò, M. Viganò, A.Lleo, P. Invernizzi, U. Vespasiani-Gentilucci, G. Hirschfield, B. Hansen, M. Carbone
Pieve Emanuele (MI), Rozzano (MI), Rome, Padua, Palermo, Milan, Bergamo, Monza, Tokyo (Japan) Birmingham (UK), Belo Horizonte (Brazil), Miami (USA), Larissa (Greece), Edmonton (Canada), Oxford (UK), Rotterdam (The Netherlands), Leuven (Belgium), Tel Aviv (Israel), Boston (USA), Buenos Aires (Argentina), Ghent (Belgium), Copenhagen (Denmark), Toronto (Canada)
PNPLA3 beyond the liver: exploring its impact on body composition in MASLD
Presenter: Francesca Alletto (Milan)
Authors: F. Alletto, A. Cespiati, R. Lombardo, F. Cinque, D. Smith, E. Pulixi, E. Fatta, P. Dongiovanni, P. Tarantini, M. Meroni, A.L. Fracanzani
Milan, Busto Arsizio (VA)
Prognostic role of acute clinical clusters of presentation in patient with HCC admitted in the ED
Presenter: Leonardo Stella (Rome)
Authors: L. Stella, G. Marrone, A. Liguori, L. Miele, M. Biolato, M. Pompili, A. Gasbarrini, F. Franceschi, F.R. Ponziani, M. Covino
Rome
10:00-10:30
STATE OF THE ART LECTURE
Targeting the gut-liver-brain axis: contemporary approaches to HE
D. Shawcross
Presenter: A. Lleo
10:30-10:45
BEST PAPER BASIC (No E.C.M.)
V. La Mura, V. Ronca
BEST PAPER CLINICAL (No E.C.M.)
Q. Lai, F. Morisco
EXHIBITION AREA
10:45-11:15
Coffee Break
ROOM GH
11:15-12:00
PARALLEL SESSION 3
Chairs: S. Fagiuoli, F.R. Ponziani
Performances of Baveno VII AND AASLD 2024 criteria for detecting gastroesophageal varices in untreated patients with HDV-related cirrhosis
Presenter: Maria Paola Anolli (Milan)
Authors: M.P. Anolli, E. Degasperi, G. Tosetti, L. Gheorghe, A. Loglio, A. Ciancio, G. D’Offizi, M. Jachs, C. Schramm, M.R. Brunetto, F. Van Bömmel, S. Zaltron, L. Turco, C. Zöllner, T.A. Santantonio, I. Carey, A. Federico, L. Sarmati, M. Buti, M. Cardoso, F. Morisco, M. Papatheodoridi, F.P. Russo, A. Mangia, P. Toniutto, N. Coppola, C. Dietz-Fricke, J. Dumortier, E.G. Giannini, E. Rosselli Del Turco, S. Aleman, S. De Nicola, P. Gatti, M. Maracci, L. Marinaro, M. Milella, A. Pellicelli, B. Pinchera, M. Puoti, D. Roulot, L.S. Crocè, I. Maida, U. Merle, A. Pan, P. Torre, F. Piler, A. Romano, M. Tonnini, P. Vitiello, R. Zampino, P. Lampertico
Milan, Bucarest (Romania), Bergamo, Turin, Rome, Vienna (Austria), Essen (Germany), Pisa, Leipzig (Germany), Brescia, Bologna, Berlin (Germany), Foggia, London (UK), Naples, Barcelona (Spain), Amadora (Portugal), Athens (Greece), Padua, San Giovanni Rotondo, Udine, Hannover (Germany), Lyon (France), Genoa, Stockholm (Sweden), Rozzano, Brindisi, Ancona, Bari, Trieste, Sassari, Heidelberg (Germany), Cremona, Baronissi, Modena, Busto Arsizio (VA)
Transjugular intrahepatic portosystemic shunt for refractory hepatic hydrothorax in patients with cirrhosis: a multicenter European study
Presenter: Carlo Alessandria (Turin)
Authors: M. Tizzani, G.P. Caviglia, L. Téllez, S. Geisselbrecht, F. Vizzutti, M. Reincke, C. Becchetti, L. Maruzzelli, D. Saltini, M. Rudler, K. Ferdinande, E. Pompili, H. Larrue, G. Tosetti, S. Nardelli, D. Campion, J. Donate, A. Tiede, S. Aspite, M. Schultheiss, M. Solcia, A. Olavarría, E. Bugianesi, G. Svegliati Baroni, M. Viganò, S. Piano, P. Toniutto, O. Riggio, V. La Mura, C. Bureau, P. Caraceni, M. Senzolo, D. Thabut, F. Schepis, R. Miraglia, A. Airoldi, D. Bettinger, F. Marra, B. Maasoumy, A. Albillos, A. Marzano, C. Alessandria
Turin, Madrid (Spain), Hannover (Germany), Florence, Freiburg (Germany), Milan, Palermo, Modena, Paris (France), Padua, Bologna, Toulouse (France), Rome, Ancona, Bergamo, Udine
Longitudinal changes of liver elastography, FIB4 and Agile3+ add prognostic significance to baseline values in patients with Metabolic dysfunction Associated Steatotic Liver Disease (MASLD)
Presenter: Antonio Liguori (Rome)
Authors: A. Liguori, L. Petrucci, F. Pantaleo, F. S.M. Youssef, G. Marrone, M. Biolato, M. Pompili, A. Grieco, A. Gasbarrini, L. Miele
Rome
Effective prevention of further complications of portal-hypertension is independent of TIPS under-dilation
Presenter: Davide Roccarina (Florence)
Authors: D. Roccarina, D. Saltini, M. Senzolo, S. Nardelli, I. Scami, T. Zurli, C. Caporali, M. Rosi, V. Adotti, M. Bianchini, L. Biribin, S. Gioia, S. Aspite, L. Ragozzino, T. Guasconi, F. Casari, A. Piscopo, F. Pindozzi, S. Gitto, A. Luca Annese, G. Gabbani, M. Gaggini, K. Ferdinande, E. Casamassima, M. Merli, L. Ridola, O. Riggio, F. Fanelli, C. Mangini, F. Marra, S. Montagnese, F. Schepis, F. Vizzutti
Florence, Modena, Padua, Pisa, Rome
PININFARINA
11:15-12:00
PARALLEL SESSION 4
Chairs: M. Carbone, M. Rendina
The Burden of Extrahepatic Comorbidities in Primary Biliary Cholangitis: Insights from the Italian National PBC Registry
Presenter: Nora Cazzagon (Padua)
Authors: N. Cazzagon, A. De Vincentis, M. Benatti, E. Nofit, F. Terracciani, E. Catanzaro, T. Zappitelli, F. Bonarrigo, G. Figorilli, M. Peviani, L. Abenavoli, G. Scarlata, G. Alagna, D. Alvaro, S. Nardelli, D. Montecalvo, P. Andreone, F. Gabrielli, F. Azzaroli, E. Dajti, L. Baiocchi, P. Carnì, F. Bellanti, S. Quiete, M.C. Bragazzi, R. Venere, F. Bronte, A. Affronti, M. Brunetto, B. Coco, V. Calvaruso, V. Di Marco, M.C. Neglia, F. Capelli, L. Pitotti, A. Castellaneta, A. De Feudis, I. Cavalli, A. Gobbi, L. Chessa, F. Pes, R. Chiavaroli, M. Graffeo, F. Cerini, F. Pavan, S. Crocè, F. Masutti, C. Cusumano, N. Passigato, S. Di Cesare, A. Granito, F. Piscaglia, N. Dal Bo’, V. Vanin, L. Fabris, A. Lasagni, S. Fagiuoli, M. Viganò, A. Federico, F. Di Nardo, E. Giannini, S. Labanca, G. Niro, R. Cotugno, E. Lynch, A. Galli, P. Lampertico, E. Degasperi, P. Lecis, A. Meneghetti, A. Lleo, F. Colapietro, A. Mangia, V. Piazzolla, F. Marra, F. Biagi, M. Marzioni, L. Maroni, A. Mega, L. Miele, F. Ponziani, G. Missale, A. Orlandini, F. Morisco, V. Cossiga, G. Nardone, A. Rocco, V. Palitti, M. Persico, M. Masarone, T. Sarcina, G. Raimondo, C. Saitta, C. Ricci, P. Poisa, C. Rigamonti, G. Manfredi, M. Russello, M. Cannavò, S. Schianchi, M. Beltrami, C. Simoni, E. Masciocchi, F. Losito, R. Cozzolongo, E. Vanni, G. Vettori, L. Moser, L. Surace, E. Falbo, R. Viganò, F. D’Amico, G. Vitale, M.C. Morelli, T. Zolfino, C. Scudu, A. Gerussi, L. Cristoferi, M. Carbone, P. Invernizzi, U. Vespasiani Gentilucci
Padua, Rome, Monza, Catanzaro, Sassari, Modena, Bologna, Foggia, Latina, Palermo, Pisa, Bari, Cremona, Monserrato, Brescia, Trieste, Verona, Treviso, Bergamo, Naples, Genoa, San Giovanni Rotondo (FG), Florence, Milan, Bassano del Grappa, Rozzano(MI), Pieve Emanuele (MI), Ancona, Bolzano, Parma, Pescara, Salerno, Messina, Novara, Catania, Reggio Emilia, Gallarate, Castellana Grotte (BA), Turin, Trento, Cagliari
Endoscopic Ultrasound-Guided Portal Venous Pressure (EUS-PVP) Measurement for Predicting Outcomes in patients with suspected portal hypertension: A Bicentric Clinical Study
Presenter: Giuseppe Tarantino (Ancona)
Authors: F. Santopaolo, G. Tarantino, M. Marzioni, L. Salvi, F. Martini, A. Alessandrini, M. Dalla Bella, C. Cavallo, L. Giuli, B.E. Annicchiarico, G. Rizzatti, G. Tripodi, A. Benedetti, A. Larghi
Rome, Ancona
Impact of non-selective beta-blockers on acute kidney injury outcomes in decompensated cirrhosis
Presenter: Simone Incicco (Padua)
Authors: S. Incicco, K.R. Patidar, A. Juanola, A.T. Ma, A. Barone, A.V. Kulkarni, J.L. Pérez Hernández, S. K. Asrani, B. Wentworth, C. Alessandria, N.A. Abdelkader, Y.J. Wong, Q. Xie, N.T. Pyrsopoulos, S.E. Kim, Y. Fouad, A. Torre, E. Cerda Reyes, J. Díaz-Ferrer, R. Maiwall, D.A. Simonetto, M. Papp, E.S. Orman, G. Perricone, C. Solé, C. M. Lange, A.Q. Farias, G. Pereira, S. Marciano, P. Caraceni, T. Thévenot, N. Verma, J.H. Kim, J.D. Vorobioff, J. Cordova-Gallardo, V. Ivashkin, R. Maan, J.P. Roblero, C. Toledo, S. Gioia, E. Fassio, M. Marino, P. Nabilou, V. Vargas, M. Merli, L. L. Goncalves, L. Rabinowich, A. Krag, L. Balcar, A. Gadano, F. Durand, S.K. Sarin, P. Ginès, P. Angeli, E. Solà, S. Piano
Padua, Turin, Milan, Bologna, Rome, São Paulo (Brasil), Buenos Aires (Argentina), Barcelona (Spain), Sabadell (Spain), Munich (Germany), Rio de Janeiro (Brasil), Besançon (France), Rosario (Argentina), Hvidovre (Denmark), Vitòria (Brasil), Tel Aviv (Israel), Odense (Denmark), Vienna (Austria), Stanford (USA)
Metabolic Reprogramming in MASH-Related HCC: The Emerging Role of G6PD as a Biomarker and Target
Presenter: Jessica Nurcis (Turin)
Authors: J. Nurcis, B. Foglia, M. Maggiora, A. Gambella, U. Chianese, C. Bocca, G.P. Caviglia, A. Caddeo, R. Bendetti, F. Bossi, P. Carucci, S. Gaia, A. Perra, R. Romagnoli, E. Bugianesi, L. Altucci, L. Varricchio, M. Parola, M. Kowalick, S. Rapposelli, S. Cannito
Turin, Genoa, Naples, Cagliari, Pisa
AUDITORIUM
12:00-13:00
SYMPOSIUM III – AUTOIMMUNE AND CHOLESTATIC LIVER DISEASES
Chairs: V. Calvaruso, P. Invernizzi
12:00
Emerging therapeutic strategies in PSC: current and advanced future horizons – D. Alvaro
12:15
Comprehensive care in PBC: recognizing, measuring,and intervening – C. Rigamonti
12:30
Uncovering genetic cholestasis in adults: diagnostic pathways and targeted therapy – M. Viganò
12:45
Discussion
EXHIBITION AREA
13:00-14:00
LUNCH & POSTER VIEW
SALA DELL’ARCHITETTURA + SALA DELL’EDITORIA
13:00-14:00
PORTAL HYPERTENSION LAB (No E.C.M.)
D. Saltini, F. Schepis, M. Senzolo, A. Zanetto
AUDITORIUM
14:00-15:00
GENERAL ASSEMBLY 3 (No E.C.M.)
AISF Governing Board
AUDITORIUM
15:00-16:00
SYMPOSIUM IV – LIVER ONCOLOGY
Chairs: G. Cabibbo, E. Giannini
15:00
Immuno-downstaging in HCC: expanding boundaries of liver transplant eligibility – S. Bhoori
15:15
The role of TARE in patients with HCC or cholangiocarcinoma: where do we stand? – L. Crocetti
15:30
Liver transplantation for cholangiocarcinoma: from exception to consensus – E. Gringeri
15:45
Discussion
AUDITORIUM
16:00-16:15
2 PREMI BEST ORAL (No E.C.M.)
M. Persico, G. Squadrito
2 PREMI BEST POSTERS (No E.C.M.)
L. Cristoferi, A. Loglio
16:15-16:30
GENERAL ASSEMBLY 4 (No E.C.M.)
AISF Governing Board
16:30-16:40
CLOSING REMARKS
AISF Governing Board